Virginia Retirement Systems’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-410,100
Closed -$10.4M 1029
2025
Q3
$10.4M Buy
410,100
+14,800
+4% +$365K 0.07% 235
2025
Q2
$9.58M Buy
395,300
+134,400
+52% +$3.13M 0.07% 236
2025
Q1
$6.61M Buy
+260,900
New +$6.83M 0.05% 261
2023
Q3
$3.44M Sell
103,711
-363,900
-78% -$12.9M 0.03% 257
2023
Q2
$17.2M Sell
467,611
-790,300
-63% -$30.8M 0.16% 164
2023
Q1
$51.3M Sell
1,257,911
-849,985
-40% -$36.7M 0.53% 45
2022
Q4
$108M Sell
2,107,896
-39,200
-2% -$1.88M 1.13% 13
2022
Q3
$94M Buy
+2,147,096
New +$104M 1.06% 15
2022
Q1
$95.5M Buy
1,844,496
+622,900
+51% +$32.3M 0.89% 18
2021
Q4
$72.1M Sell
1,221,596
-55,100
-4% -$2.73M 0.49% 35
2021
Q3
$54.9M Sell
1,276,696
-73,300
-5% -$3.25M 0.56% 40
2021
Q2
$52.9M Buy
1,349,996
+84,600
+7% +$3.29M 0.52% 46
2021
Q1
$45.8M Buy
1,265,396
+490,600
+63% +$17.4M 0.45% 55
2020
Q4
$28.5M Buy
774,796
+9,702
+1% +$356K 0.3% 85
2020
Q3
$26.6M Sell
765,094
-1,160
-0.2% -$40.7K 0.3% 84
2020
Q2
$23.8M Sell
766,254
-738
-0.1% -$25.1K 0.28% 86
2020
Q1
$23.8M Buy
766,992
+79,367
+12% +$2.7M 0.33% 72
2019
Q4
$25.6M Sell
687,625
-633,876
-48% -$22.6M 0.28% 89
2019
Q3
$45M Sell
1,321,501
-130,274
-9% -$4.74M 0.51% 38
2019
Q2
$59.7M Buy
1,451,775
+3,267
+0.2% +$130K 0.69% 23
2019
Q1
$58.4M Buy
1,448,508
+632,400
+77% +$25.3M 0.69% 21
2018
Q4
$33.8M Sell
816,108
-37,522
-4% -$1.56M 0.46% 49
2018
Q3
$35.7M Sell
853,630
-217,862
-20% -$8.39M 0.41% 52
2018
Q2
$36.9M Sell
1,071,492
-199,733
-16% -$6.83M 0.45% 49
2018
Q1
$42.8M Hold
1,271,225
0.52% 35
2017
Q4
$43.7M Sell
1,271,225
-1,581
-0.1% -$53.9K 0.52% 38
2017
Q3
$43.1M Buy
1,272,806
+257,176
+25% +$8.27M 0.52% 36
2017
Q2
$32.4M Hold
1,015,630
0.41% 49
2017
Q1
$33M Sell
1,015,630
-36,996
-4% -$1.17M 0.42% 44
2016
Q4
$32.4M Sell
1,052,626
-323,156
-23% -$9.87M 0.45% 48
2016
Q3
$44.2M Hold
1,375,782
0.64% 27
2016
Q2
$46M Buy
+1,375,782
New +$43.9M 0.68% 22
2015
Q4
$47.3M Buy
1,543,502
+312,029
+25% +$9.82M 0.71% 26
2015
Q3
$36.7M Buy
1,231,473
+18,448
+2% +$592K 0.56% 33
2015
Q2
$38.6M Sell
1,213,025
-6,823
-0.6% -$222K 0.59% 30
2015
Q1
$40.3M Buy
1,219,848
+62,356
+5% +$1.98M 0.61% 31
2014
Q4
$34.2M Buy
1,157,492
+32,401
+3% +$929K 0.53% 41
2014
Q3
$31.6M Buy
1,125,091
+18,584
+2% +$522K 0.52% 42
2014
Q2
$31.2M Sell
1,106,507
-7,697
-0.7% -$219K 0.54% 36
2014
Q1
$34M Buy
1,114,204
+22,352
+2% +$666K 0.64% 25
2013
Q4
$31.7M Buy
1,091,852
+162,842
+18% +$4.74M 0.63% 29
2013
Q3
$25.3M Sell
929,010
-274,784
-23% -$7.48M 0.54% 51
2013
Q2
$32M Buy
+1,203,794
New +$33.3M 0.6% 47

Other funds holding PFE

Virginia Retirement Systems's PFE Position: Q4 2025 in Review

Virginia Retirement Systems sold out of Pfizer (PFE) in Q4 2025, closing a stake of 410,100 shares — an estimated $10.4M sold.

Virginia Retirement Systems first reported a position in PFE in Q2 2013 and held it in 43 quarters. The position peaked at $108M in Q4 2022. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Virginia Retirement Systems reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Virginia Retirement Systems sold 410,100 Pfizer shares in Q4 2025, an estimated $10.4M.
  • Virginia Retirement Systems first reported a position in Pfizer in Q2 2013 and held it in 43 quarters.
  • Virginia Retirement Systems's Pfizer position peaked at $108M in Q4 2022.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.